Itf Therapeutics Appoints Erica L. Monaco As Chief Operating Officer

Dec 04, 2024•8 months ago

Position

Chief Operating Officer

Company

ITF Therapeutics

Erica L. Monaco

ConcordTherapeuticsBiotechnologyHealth Care

Description

ITF Therapeutics LLC announced the appointment of Erica L. Monaco, CPA, as chief operating officer. Erica brings nearly two decades of experience in the pharmaceutical and financial sectors and will oversee a broad range of strategic and operational functions, supporting the U.S

Company Information

Company

ITF Therapeutics

Location

Concord, Massachusetts, United States

About

ITF Therapeutics was launched in January 2024 as the U.S. affiliate of Italfarmaco focused on the development and commercialization of products to treat rare diseases. Building on a legacy grounded in collaboration and innovation, ITF Therapeutics strives to partner with leaders from the patient advocacy and treatment communities to ensure that our programs reflect and support their unique needs and goals.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months